Not finding it? Sign in to also search OpenAlex live.
-
EXCELLERATP2 D3.2 First Updated Report on Exa-Enabling Methodologies2026 Zenodo (CERN European Organization for Nuclear Research) article Computer Science Parallel Computing and Optimization Techniques Open access
Ansgar Niemöller, Matthias H. Meinke, Joeffrey Legaux, Mohamed Ibrahim Ghenai, Michael Wagner, Tufan Arslan, +12 more
0citations -
EXCELLERATP2 D3.2 First Updated Report on Exa-Enabling Methodologies2026 Zenodo (CERN European Organization for Nuclear Research) article Engineering Computational Fluid Dynamics and Aerodynamics Open access
Ansgar Niemöller, Matthias H. Meinke, Joeffrey Legaux, Mohamed Ibrahim Ghenai, Michael Wagner, Tufan Arslan, +12 more
0citations -
6877 Withdrawing Growth Hormone Treatment at Mid-Puberty in Idiopathic Isolated Growth Hormone Deficiency: Baseline Characteristics in Patient-Preference Design Study2024 Journal of the Endocrine Society article Medicine Growth Hormone and Insulin-like Growth Factors Open access
Joeri Vliegenthart, Jan-Maarten Wit, Boudewijn Bakker, Annemieke M. Boot, Christiaan de Bruin, Martijn Finken, +15 more
0citations -
9262 Withdrawing Growth Hormone Treatment at Mid-Puberty in Idiopathic Isolated Growth Hormone Deficiency: Baseline Characteristics in Patient-Preference Design Study2024 Journal of the Endocrine Society article Medicine Growth Hormone and Insulin-like Growth Factors Open access
Joeri Vliegenthart, Jan-Maarten Wit, Boudewijn Bakker, Annemieke M. Boot, Christiaan de Bruin, Martijn J.J. Finken, +15 more
0citations -
Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
Steffen Koschmieder, Susanne Isfort, Florian Heinrich Heidel, Andreas Hochhaus, Heiko Becker, Philipp Jakob Jost, +19 more
3citations -
P191 Efficacy and improvement in patient-reported outcomes at weeks 16 and 52 in ixekizumab treated biological naïve patients with radiographic axial spondyloarthritis achieving clinically important pain at night reduction at week 16: results from COAST-V trial
Sofía Ramiro, Cédric Lukas, Michael John Nissen, Yves Schymura, Khai Jing Ng, Gabriel Doridot, +3 more
0citations